Valmet Corp. (0QIW)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 26.97 |
|---|---|
| 52-week range | 20.74 – 30.36 |
| Return, 1 month / 3 months | −2.5% / +2.9% |
| Return, 1 year / 3 years | −2.3% / +52.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 34.0% |
| Worst drawdown (1 year) | -28.7% |
| Average daily value traded | 2.81M EUR |
| Dividend yield | 5.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Valmet is a Finnish engineering company that supplies machinery, equipment and automation for the pulp, paper and board industries. It builds paper and board machines, pulp production lines and related process equipment, and provides automation and flow control systems for industrial customers. Its clients include pulp mills, paper and board producers, and energy and process industry operators, and the company is based in Finland and serves customers around the world.
On this site Valmet Corp. appears as a stock on the London Stock Exchange (UK), code 0QIW, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Valmet Corp. (0QIW) trades on the London Stock Exchange in UK. It last closed at EUR 26.97 on 27 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,196 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.3% and over the last three months it rose 2.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.8% | ||
| From 52-week high | -10.5% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 2.9% | ||
| 6-month return | 13.8% | ||
| 12-month return, skipping the last month | 0.1% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.7% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.81M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −2.5% |
| 3 months | +2.9% |
| 6 months | +13.8% |
| 1 year | −2.3% |
| 3 years | +52.3% |
| 5 years | −0.8% |
Signals
| 50-day / 200-day average | 27.36 / 25.01 |
|---|---|
| Golden / death cross (60 days) | Golden, 34 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2026 | EUR 0.6700 |
| 26 Mar 2026 | EUR 0.6800 |
| 26 Sep 2025 | EUR 0.6700 |
| 27 Mar 2025 | EUR 0.6800 |
| 30 Sep 2024 | EUR 0.6700 |
| 25 Mar 2024 | EUR 0.6800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.